Results 91 to 100 of about 1,099,667 (293)

Behavioral risk factors that predispose women to vaginal infections in Turkey

, 2010
Objective: Vaginal infections are common and when they are not treated, they can cause serious health problems such as getting infected with Human Immunodeficiency Virus (HIV).
Taskin, Lale, Kisa, Sezer
core   +1 more source

Method for diagnosis vaginal infections

, 2014
The present invention relates to diagnostic methods for evaluating vaginal infections comprising the use of specific proteins. The invention further relates to the use of specific proteins in a diagnostic method for evaluating recovery from the ...
Giuseppe Claudio Viscomi, Fiorella Calanni, VITALI, BEATRICE, CRUCIANI, FEDERICA   +3 more
core  

Associations of vaginal carriage of bacterial taxa with common vaginal infections.

, 2014
Bootstrap (n = 1,000) samples were selected from the outpatient clinic population to reflect the outpatient community composition. Median relative risk and 95% bootstrap confidence intervals are shown.
Myrna G. Serrano (210460), Gregory A. Buck (184803), Kimberly K. Jefferson (606981), J. Paul Brooks (109797), Abigail L. Glascock (648279), Jennifer M. Fettweis (648277), Nihar U. Sheth (648280), Bernice Huang (648278), Jerome F. Strauss III (154814)   +8 more
core   +1 more source

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments—A VigiBase Disproportionality Analysis Study

Clinical Pharmacology &Therapeutics, EarlyView.
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian, Floriane Jochum, Elise Dumas, Florence Coussy, Kevin Bihan, Bénédicte Lebrun‐Vignes, Barbara Pistilli, Marc‐Antoine Benderra, Lise Selleret, Laurent Chouchana, Fabien Reyal, Anne‐Sophie Hamy, Paul Gougis   +12 more
wiley   +1 more source

Current issues in therapy of vaginal infections during gestation [PDF]

Гинекология, 2016
Infections of the reproductive tract caused by various representatives of the vaginal microbiota have been associated with increased risk of pregnancy complications.
Yu E Dobrokhotova, L A Ozolinia, K R Bondarenko, I A Lapina, A S Dvornikov   +4 more
doaj  

Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India. [PDF]

, 2012
BACKGROUND: Vulvovaginal candidiasis is characterized by curd-like vaginal discharge and itching, and is associated with considerable health and economic costs.
Madhivanan, Purnima, Rathod, Sujit, Rhinegold, Arthur R., Krupp, Karl, Klausner, Jeffrey D., Rathod, Sujit D, Reingold, Arthur L, Rathod, Sujit D., Klausner, Jeffrey D, Reingold, Arthur L.   +9 more
core   +1 more source

Urogenital Infection Risk Associated With SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Target Trial Emulation

Clinical Pharmacology &Therapeutics, EarlyView.
Although sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are recommended for patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), concerns regarding urogenital infections persist. Therefore, we evaluated the risk of urinary tract infection (UTI) and genital tract infection (GTI) after SGLT2i initiation in this population ...
Young‐Mi Ah, Junsung Nam, Jung Wook Youn, Yun Mi Yu, Soyoung Kang   +4 more
wiley   +1 more source

A non-antibiotic antimicrobial drug, a biological bacteriostatic agent, is useful for treating aerobic vaginitis, bacterial vaginosis, and vulvovaginal candidiasis

Frontiers in Microbiology
BackgroundVaginitis is a common infection in women, with approximately 75% of women experiencing at least one episode during their lifetime. Although antimicrobial agents are widely used to treat vaginitis, recurrent vaginitis occurs in some patients ...
Zhen Zeng, Pei Li, Jiayi Lu, Xiaoqi Li, Meng Li, Yifan Wu, Minzi Zheng, Yang Cao, Qinping Liao, Zhaojia Ge, Lei Zhang, Lei Zhang   +11 more
doaj   +1 more source

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches

Clinical Pharmacology &Therapeutics, EarlyView.
Antiretroviral pre‐exposure prophylaxis (PrEP) is less effective in women than expected, partly because drug exposure within the female genital tract is variable and may be influenced by the vaginal microbiome. We developed an integrated pharmacometrics and machine learning framework to evaluate associations between vaginal microbiome composition and ...
Diqin Yan, Lindsey B. Collins, Christopher Staley, Flavia Kiweewa Matovu, Pamala Jacobson, Melanie Nicol, Shen Cheng   +6 more
wiley   +1 more source

Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. [PDF]

, 2009
OBJECTIVES: A randomized, double-blind, placebo-controlled trial (RCT) of herpes simplex virus type 2 suppressive therapy with acyclovir 400 mg twice daily conducted among women in northwestern Tanzania reported a similar rate of HIV acquisition in both ...
Clayton, Tim, Tanton, Clare, Ross, David, Changalucha, John, Baisley, Kathy, Weiss, Helen A, Watson-Jones, Deborah, Chirwa, Tobias, Hayes, Richard, Everett, Dean   +9 more
core   +1 more source